The Skin of Color Society’s Meeting the Challenge Summit, 2022Diversity in Dermatology Clinical Trials Proceedings

Accepted for Publication: April 2, 2023.

Published Online: May 24, 2023. doi:10.1001/jamadermatol.2023.1285

Corresponding Author: Valerie M. Harvey, MD, MPH, Hampton Roads Center for Dermatology, 860 Omni Blvd, Ste 112, Newport News, VA 23606 (valerieharvey10@gmail.com).

Author Contributions: Dr Harvey had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Cobb, Heath, McKinley-Grant, Callender, Adamson, Brown, Desai, Glass, Jaleel, Okoye, Taylor, Harvey.

Acquisition, analysis, or interpretation of data: Cobb, Byrd, Jaleel, Okoye, Taylor, Harvey.

Drafting of the manuscript: Cobb, Callender, Harvey.

Critical revision of the manuscript for important intellectual content: Cobb, Heath, Byrd, McKinley-Grant, Adamson, Brown, Desai, Glass, Jaleel, Okoye, Taylor, Harvey.

Statistical analysis: Cobb.

Obtained funding: Cobb.

Administrative, technical, or material support: Cobb, Brown, Okoye, Harvey.

Supervision: Cobb, Heath, McKinley-Grant, Callender, Desai, Jaleel, Taylor.

Conflict of Interest Disclosures: Dr Byrd reported being the recipient of the Skin of Color Society’s Career Development Award to support professional development and research efforts, the Society for Investigative Dermatology Freinkel Diversity Fellowship Award, and the Robert A. Winn Diversity in Clinical Trials Career Development Award funded by the Bristol Myers Squibb Foundation; she is also a consultant for Senté and Sonoma Biotherapeutics outside the submitted work. Dr McKinley-Grant reported personal fees from Janssen during the conduct of the study and served as the past president of the Skin of Color Society. Dr Callender reported grants from AbbVie, Dermavant, Galderma, Janssen, L’Oreal, Lilly, and UCB during the conduct of the study; grants from Acne Store, Almirall, Aerolase, Avava, Avita Medical, Beiersdorf, Cutera, Epi Health, IKNOW Skincare, Incyte, Juenesse Aesthetics, OrthoDerm, Pfizer, Prollenium, Scientis, Sente, SkinBetter Science, SkinCeuticals, Symatese, and Teoxane, as well as personal fees from UpToDate outside the submitted work; and serving as a founding member and past president of the Skin of Color Society. Dr Desai reported serving as past president of the Skin of Color Society and is the president-elect of the American Academy of Dermatology; he also serves as a researcher and/or consultant for Pfizer, Lilly, AbbVie, Bristol Myers Squibb, and Galderma. Dr Glass reported personal fees from Pfizer, UCB, and AbbVie outside the submitted work and served as past president of the Skin of Color Society. Dr Jaleel reported grants from Pfizer, the Skin of Color Society, the Dermatology Foundation, and the National Institutes of Health Building Interdisciplinary Research Careers in Women’s Health (K12HD043446), as well as personal fees from UCB, Lilly, Novartis, and ChemoCentryx outside the submitted work. Dr Okoye reported grants from Janssen and Pfizer; personal fees from Unilever, Novartis, Lilly, AbbVie, Sanofi, and UCB; and serving on the board of the HS Foundation outside the submitted work. Dr Taylor reported personal fees from AbbVie, Arcutis Biotherapeutics, Armis, Avita Medical, Beiersdorf, Biorez, Bristol Myers Squibb, Cara Therapeutics, Dior, Lilly, EPI Health, Evolus, Galderma, Glogetter, Hugel America, Johnson & Johnson, L’Oreal, MedScape, MJH Life Sciences, Pfizer, Piction Health, Sanofi, Scientis, UCB, Vichy Laboratoires, McGraw Hill, and Mercer Strategies; grants from Allergan Aesthetics, Concert Pharmaceuticals, Croma-Pharma GmbH, Lilly, Pfizer, all outside the submitted work; and serving as past president of the Skin of Color Society. Dr Harvey reported grants from AbbVie, Arcutis Biotherapeutics, Bristol Myers Squibb, Dermavant, Eli Lilly, Galderma, Google, Janssen, L’Oreal, Revision Skincare, Sanofi/Regeneron, UCB, and Vial during the conduct of the study; serving on the advisory boards of UCB, Skinceuticals, AbbVie, and Bristol Myers Squibb; serving as a consultant for L’Oreal, Novartis, and Unilever; and serving as the current president of the Skin of Color Society. No other disclosures were reported.

Disclaimer: Dr Adamson is an Associate Editor and Web Editor of JAMA Dermatology but was not involved in any of the decisions regarding review of the manuscript or its acceptance.

Additional Contributions: We thank the family of Henrietta Lacks for sharing their advice and experiences, as well as the many clinical trial participants who shared their stories at the summit. We also thank Janice Ayarzagoitia, MA, and Kimberly Miller, BA, of TREX & Medical Society Management, which manages the Skin of Color Society, for their help with the summit. Finally, we thank the Meeting the Challenge Summit: Diversity in Dermatology Clinical Trials task force members and the Skin of Color Society officers and board of directors for their support.

Additional Information: The Skin of Color Society’s Meeting the Challenge Summit was supported by AbbVie, Janssen, Bristol Myers Squibb, Lilly, Arcutis Biotherapeutics, Dermavant, Galderma, Google, Sanofi/Regeneron, L’Oreal, Revision Skincare, UCB, and Vial.